-
EP2438046
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2438046
| EP2438046 - O-GLCNAC TRANSFERASE INHIBITORS AND USES THEREOF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.04.2018 Database last updated on 16.07.2024 | |
| Former | Examination is in progress Status updated on 20.12.2016 | Most recent event Tooltip | 13.04.2018 | Application deemed to be withdrawn | published on 16.05.2018 [2018/20] | Applicant(s) | For all designated states President and Fellows of Harvard College 17 Quincy Street Cambridge, MA 02138 / US | [2012/15] | Inventor(s) | 01 /
WALKER KAHNE, Suzanne 14 Corey Road Brookline, MA 02445 / US | 02 /
LAZARUS, Michael, Block 130 Berkeley Street W. Newton, MA 02465 / US | 03 /
GROSS, Benjamin, J. 1318 Waverly Road Gladwyne, PA 19035 / US | [2012/15] | Representative(s) | Crooks, Elizabeth Caroline, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [N/P] |
| Former [2012/15] | Crooks, Elizabeth Caroline, et al Kilburn & Strode LLP 20 Red Lion Street London WC1R 4PJ / GB | Application number, filing date | 10783701.5 | 01.06.2010 | WO2010US01596 | Priority number, date | US20090217514P | 01.06.2009 Original published format: US 217514 P | [2012/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2010141074 | Date: | 09.12.2010 | Language: | EN | [2010/49] | Type: | A2 Application without search report | No.: | EP2438046 | Date: | 11.04.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.12.2010 takes the place of the publication of the European patent application. | [2012/15] | Search report(s) | International search report - published on: | KR | 31.03.2011 | (Supplementary) European search report - dispatched on: | EP | 20.03.2013 | Classification | IPC: | C07D215/04, C07D401/12, C07D215/36, C07D405/12, C07D409/14, C07D417/12, A61K31/4704, A61P3/10 | [2013/11] | CPC: |
C07D417/12 (EP,US);
A61P1/04 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P13/08 (EP);
A61P13/10 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P17/00 (EP);
A61P17/06 (EP);
A61P17/14 (EP);
A61P19/02 (EP);
A61P21/00 (EP);
A61P21/04 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P27/16 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/10 (EP);
A61P31/04 (EP);
A61P31/12 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P37/00 (EP);
A61P43/00 (EP);
A61P5/14 (EP);
A61P7/00 (EP);
A61P7/06 (EP);
A61P9/00 (EP);
C07D215/36 (EP,US);
|
| Former IPC [2012/15] | C07D215/04, C07D401/12, A61K31/4704, A61P3/10 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/15] | Title | German: | O-GLCNAC-TRANSFERASEHEMMER UND VERWENDUNGEN DAVON | [2012/15] | English: | O-GLCNAC TRANSFERASE INHIBITORS AND USES THEREOF | [2012/15] | French: | INHIBITEURS DE LA O-GLCNAC TRANSFÉRASE ET LEURS UTILISATIONS | [2012/15] | Entry into regional phase | 21.12.2011 | National basic fee paid | 21.12.2011 | Search fee paid | 21.12.2011 | Designation fee(s) paid | 21.12.2011 | Examination fee paid | Examination procedure | 21.12.2011 | Examination requested [2012/15] | 03.08.2012 | Loss of particular rights, legal effect: Claims | 10.09.2012 | Despatch of communication of loss of particular rights: Claims {1} | 10.02.2014 | Amendment by applicant (claims and/or description) | 14.10.2015 | Despatch of a communication from the examining division (Time limit: M06) | 22.04.2016 | Reply to a communication from the examining division | 12.08.2016 | Invitation to indicate the basis for amendments (Time limit: M01) | 09.09.2016 | Reply to an invitation to indicate the basis for amendments | 09.12.2016 | Despatch of a communication from the examining division (Time limit: M04) | 19.04.2017 | Reply to a communication from the examining division | 31.05.2017 | Despatch of a communication from the examining division (Time limit: M06) | 12.12.2017 | Application deemed to be withdrawn, date of legal effect [2018/20] | 10.01.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2018/20] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 14.10.2015 | Request for further processing for: | The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application | 10.02.2014 | Request for further processing filed | 10.02.2014 | Full payment received (date of receipt of payment) Request granted | 16.04.2014 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 10.02.2014 | Request for further processing filed | 10.02.2014 | Full payment received (date of receipt of payment) Request granted | 16.04.2014 | Decision despatched | Fees paid | Renewal fee | 26.06.2012 | Renewal fee patent year 03 | 20.12.2013 | Renewal fee patent year 04 | 30.06.2014 | Renewal fee patent year 05 | 29.06.2015 | Renewal fee patent year 06 | 27.06.2016 | Renewal fee patent year 07 | 27.06.2017 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 30.06.2013 | 04 M06 Fee paid on 20.12.2013 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2007120638 (HARVARD COLLEGE [US], et al) [X] 1,2,6-8 * pages 16,17; claim 1; compound 9 *; | [X]WO2009036341 (UNIV MICHIGAN [US], et al) [X] 1,2,6-8 * page 84 *; | [X] - ANNA MARIA ALMERICO ET AL, "In-silico screening of new potential Bcl-2/Bcl-xl inhibitors as apoptosis modulators", JOURNAL OF MOLECULAR MODELING, SPRINGER VERLAG, DE, (20081206), vol. 15, no. 4, ISSN 0948-5023, pages 349 - 355, XP019724180 [X] 1,2,6-8 * compound 16 * DOI: http://dx.doi.org/10.1007/s00894-008-0405-x | [X] - ANNA L BOWMAN ET AL, "Small Molecule Inhibitors of the MDM2-p53 Interaction Discovered by Ensemble-Based Receptor Models", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, ACS PUBLICATIONS, US, vol. 129, no. 42, doi:10.1021/JA073687X, ISSN 0002-7863, (20071024), pages 12809 - 12814, (20070929), XP008148630 [X] 1,2,6-8 * p. S7 (suppl. inf.) * DOI: http://dx.doi.org/10.1021/ja073687x | [X] - "Benzenepropanamide, N-(2-chlorophenyl)-.alpha.-[[(1,2,3,4-tetrahydro-2-oxo-6-quinolinyl)sulfonyl]amino]-, (.alpha.S)-", REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20090121), Database accession no. 1094798-35-2, XP002691454 [X] 5 * the whole document * | International search | [X]WO2007120638 (HARVARD COLLEGE [US], et al); | [X]WO2009036341 (UNIV MICHIGAN [US], et al); | [X] - ALMERICO, A.M. ET AL., "In-silico screening of new potential Bcl-2/Bcl-xl inhibitors as apoptosis modulators.", JOURNAL OF MOLECULAR MODELING., (2009), vol. 15, no. 4, pages 349 - 355, XP019724180 DOI: http://dx.doi.org/10.1007/s00894-008-0405-x | [X] - BOWMAN, A.L. ET AL., "Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models.", JOURNAL OF AMERICAN CHEMICAL SOCIETY, (2007), vol. 129, no. 42, pages 12809 - 12814, XP008148630 DOI: http://dx.doi.org/10.1021/ja073687x |